Dr. Richard Bradley Moore, MD

Dr. Moore practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Moore's NPI, 1750606505, was assigned on April 6, 2010. Dr. Moore graduated from McGovern Medical School in 2010. Dr. Moore holds Texas license Q0124.

Dr. Moore's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Moore's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Moore is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Moore to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Moore is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Moore's licenses on file in 2 states: Texas and Virginia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Moore treats.

CMS data shows 1,904 Medicare services from Dr. Moore across 12 procedure codes in 2024, for 620 Medicare patients. Medicare paid $113,658 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 620 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 76, with 61% women.

In 2024, Dr. Moore wrote 7,506 Medicare Part D claims for 1,153 patients. 78% of them were for generic drugs. CMS names the drug for 7,384 of them, across 27 drugs with 11 or more claims each, at $456,436 in total drug cost. In 2023, CMS named 6,742 claims across 23 drugs.

Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 112 procedures of cataract surgery by Dr. Moore, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Moore in 2013. Dr. Moore's most frequent co-author is Ruth Helen Walker, MBCHB, PhD.

CMS Open Payments shows 5 general payments to Dr. Moore from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $33.

Dr. Moore graduated from McGovern Medical School in 2010. Dr. Moore is a member of AAO, American Society of Cataract and Refractive Surgeons, Christian Ophthalmology Society, TMA and Texas Ophthalmological Association.

Dr. Moore is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.